Skip to main content
. 2016 Nov 15;8(11):4912–4921.

Figure 3.

Figure 3

PMSCs treatment regulates secretion of inflammatory factors. Inflammatory factors in blood circulation were determined at indicated time points. PMSCs treatment can effectively inhibit secretion of pro-inflammatory factors, TNF-α (A), IL-1 (B) and IL-6 (C) and promote secretion of anti-inflammatory factor, IL-10 (D). The data were presented as mean ± SEM; *P < 0.05.